Echocardiographic assessment of hypertensive patients with or without hyperhomocysteinemia

References

• Gardin JM, Drayer JI, Weber M, et al. Doppler echocardiographic assessment of left ventricular systolic and diastolic function in mild hypertension. Hypertension 1987;9:90–6
   Web of Science ®Google Scholar
• Tarazi RC. The heart in hypertension. N Engl J Med 1985;312:308–9
   PubMed Web of Science ®Google Scholar
• Lim U, Cassano PA. Homocysteine and blood pressure in the 3rd National Health and Nutrition Examination Survey, 1988–1994. Am J Epidemiol 2002;156:1105–13
   PubMed Web of Science ®Google Scholar
• Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202
   PubMed Web of Science ®Google Scholar
• Shankar A, Wang JJ, Chua B, et al. Positive association between plasma homocysteine level and chronic kidney disease. Kidney Blood Press Res 2008;31:55–62
   PubMed Web of Science ®Google Scholar
• Ambrosch A, Dierkes J, Lobmann R, et al. Relation between homocysteinaemia and diabetic neuropathy in patients with type 2 diabetes mellitus. Diabet Med 2001;18:185–92
   PubMed Web of Science ®Google Scholar
• Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288:2015–22
   PubMed Web of Science ®Google Scholar
• Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 1995;26:135–6
   PubMedGoogle Scholar
• Takasaki K, Miyata M, Imamura M, et al. Left ventricular dysfunction assessed by cardiac time interval analysis among different geometric patterns in untreated hypertension. Circ J 2012;76:1409–14
   PubMed Web of Science ®Google Scholar
• Schwammenthal E, Adler Y, Amichai K, et al. Prognostic value of global myocardial performance indices in acute myocardial infarction. Chest 2003;124:1645–51
   PubMed Web of Science ®Google Scholar
• Bruch C, Schmermund A, Marin D, et al. Tei-Index in patients with mild-to-moderate congestive heart failure. Eur Heart J 2000;21:1888–95
   PubMed Web of Science ®Google Scholar
• Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med 1992;117:502–10
   PubMed Web of Science ®Google Scholar
• Perrone-Filardi P, Bacharach SL, Dilsizian V, et al. Effects of regional systolic asynchrony on left ventricular global diastolic function in patients with coronary artery disease. J Am Coll Cardiol 1992;19:739–44
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Nishimura RA, Chaliki HP, et al. Determination of left ventricular filling pressure by Doppler echocardiography in patients with coronary artery disease: critical role of left ventricular systolic function. J Am Coll Cardiol 1997;30:1819–26
   PubMed Web of Science ®Google Scholar
• Boudoulas H. Diastolic time: the forgotten dynamic factor. Implications for myocardial perfusion. Acta Cardiol 1991;46:61–71
   PubMed Web of Science ®Google Scholar
• Brazier J, Cooper N, Buckberg G. The adequacy of subendocardial oxygen delivery: the interaction of determinants of flow, arterial oxygen content and myocardial oxygen need. Circulation 1974;49:968–77
   PubMed Web of Science ®Google Scholar
• Ascione L, De Michele M, Accadia M, et al. Myocardial global performance index as a predictor of in-hospital cardiac events in patients with first myocardial infarction. J Am Soc Echocardiogr 2003;16:1019–23
   PubMed Web of Science ®Google Scholar
• Pellett AA, Tolar WG, Merwin DG, et al. The Tei index: methodology and disease state values. Echocardiography 2004;21:669–72
   PubMed Web of Science ®Google Scholar
• Tei C, Nishimura RA, Seward JB, et al. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterizeation measurements. J Am Soc Echocardiogr 1997;9:169–78
   Google Scholar
• Badiou S, Dupuy AM, Jaussent I, et al. Homocysteine as a determinant of left ventricular ejection fraction in patients with diabetes. Clin Chem Lab Med 2012;50:1099–106
   PubMed Web of Science ®Google Scholar
• Vasan RS, Beiser A, D'Agostino RB, et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. Cardiol J 2003;289:1251–7
   Google Scholar
• Agoston-Coldea L, Mocan T, Gatfosse M, et al. Plasma homocysteine and the severity of heart failure in patients with previous myocardial infarction. Cardiol J 2011;18:55–62
   PubMed Web of Science ®Google Scholar
• Joseph J, Shekhawat NS, Devi S, et al. Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. Am J Physiol Heart Circ Physiol 2003;285:H679–86
   PubMed Web of Science ®Google Scholar
• Wocial B, Berent H, Kostrubiec M, et al. Homocysteine, adrenergic activity and left ventricular mass in patients with essential hypertension. Blood Press 2002;11:201–5
   PubMed Web of Science ®Google Scholar
• Cesari M, Zanchetta M, Burlina A, et al. Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives. Arterioscler Thromb Vasc Biol 2005;25:115–21
   PubMed Web of Science ®Google Scholar
• Lentz SR. Homocysteine and vascular dysfunction. Life Sci 1997;61:1205–15
   PubMed Web of Science ®Google Scholar
• Zhou J, Austin RC. Contributions of hyperhomocysteinemia to atherosclerosis: causal relationship and potential mechanisms. Biofactors 2009;35:120–9
   PubMed Web of Science ®Google Scholar
• Zivkovic V, Jakovljevic V, Djordjevic D, et al. The effects of homocysteine-related compounds on cardiac contractility, coronary flow, and oxidative stress markers in isolated rat heart. Mol Cell Biochem 2012;370:59–67
   PubMed Web of Science ®Google Scholar
• Alter P, Rupp H, Rominger MB, et al. Association of hyperhomocysteinemia with left ventricular dilatation and mass in human heart. Clin Chem Lab Med 2010;48:555–60
   PubMed Web of Science ®Google Scholar
• Dierkes J, Westphal S. Effect of drugs on homocysteine concentrations. Semin Vasc Med 2005;5:124–39
   PubMedGoogle Scholar
• Guéant Rodriguez RM, Spada R, Pooya S, et al. Homocysteine predicts increased NT-pro-BNP through impaired fatty acid oxidation. Int J Cardiol 2012 . [Epub ahead of print]. doi:10.1016/j.ijcard.2012.03.047
   PubMed Web of Science ®Google Scholar
• Sundstrom J, Vasan RS. Homocysteine and heart failure: a review of investigations from the Framingham Heart Study. Clin Chem Lab Med 2005;43:987–92
   PubMed Web of Science ®Google Scholar
• Reddy HK, Tjahja IE, Campbell SE, et al. Expression of matrix metalloproteinase activity in idiopathic dilated cardiomyopathy: a marker of cardiac dilatation. Mol Cell Biochem 2004;264:183–91
   PubMed Web of Science ®Google Scholar
• Au-Yeung KK, Woo CW, Sung FL, et al. Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress. Circ Res 2004;94:28–36
   PubMed Web of Science ®Google Scholar